A double-blind pilot study of risperidone in the treatment of conduct disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 4, 2000, Pages 509-516

  Findling, Robert L ^a   Mcnamara, Nora K ^a   Branicky, Lisa A ^a   Schluchter, Mark D ^a   Lemon, Eloise ^a   Blumer, Jeffrey L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Antipsychotic; Conduct disorder; Risperidone; Treatment

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; APPETITE DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ENURESIS; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; NAUSEA; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESSNESS; SCHOOL CHILD; SEDATION; VOMITING;

EID: 0034087445     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200004000-00021     Document Type: Article

References (28)

1. Achenbach TM (1991), Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington: University of Vermont Department of Psychiatry
2. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
3. Campbell M, Adams PB, Small AM et al. (1995), Lithium in hospitalized aggressive children with conduct disorder a double-blind and placebo-comrolled study. J Am Acad Child Adolesc Psychiatry 34:445-453
4. Campbell M, Cohen IL, Small AM (1982), Drugs in aggressive behavior. J Am Acad Child Psychiatry 21:107-117
5. Campbell M, Small AM, Green WH et al. (1984), Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 41:650-656
6. Conners CK (1989), Manual for Conners' Rating Scales. North Tonawanda, NY: Multi-Health Systems
7. Dunn LM, Dunn LM (1981), Peabody Picture Vocabulary Test-Revised, Manual for Forms L and M. Circle Pines, MN: American Guidance Service
8. Findling RL, Maxwell K, Wiznitzer M (1997), An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull 33:155-159
9. Findling RL, Schulz SC, Reed MD, Blumer JL (1998), The antipsychotics: a pediatric perspective. Pediatr Clin North Am 45:1205-1232
10. Fisman S, Steele M (1996), Use of risperidone in pervasive developmental disorders: a case series. J Child Adolesc Psychopharmacol 6:177-190
11. Fras I, Major LF (1995), Clinical experience with risperidone (letter). J Am Acad Child Adolesc Psychiatry 34:833
12. Greenhill LL, Solomon M, Pleak R, Ambrosini P (1985), Molindone hydrochloride treatment of hospitalized children with conduct disorder. J Clin Psychiatry 46(8, sect 2):20-25
13. Horrigan JP, Barnhill LJ (1997), Risperidone and explosive aggressive autism. J Autism Dev Disord 27:313-323
14. Janssen PAJ, Niemegeers CJE, Awouters F, Schellekens KHL, Megens AAHP, Meert TF (1988), Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685-693
15. Jensen PS, Vitiello B, Leonard H, Laughren TP (1994), Child and adolescent psychopharmacology: expanding the research base. Psychopharmacol Bull 30:3-8
16. Kaplan SL, Simms RM, Busner J (1994), Prescribing practices of outpatient child psychiatrists. J Am Acad Child Adolesc Psychiatry 33:35-44
17. Kemph JP, De Vane CL, Levin GM, Jarecke R, Miller RL (1993), Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiatry 32:577-581
18. Little RJA (1995), Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc 90:1112-1121
19. Marder SR, Meibach RC (1994), Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-835
20. McDougle CJ, Holmes JP, Bronson MR et al. (1997), Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Am Acad Child Adolesc Psychiatry 36:685-693
21. National Institute of Mental Health (1985a), CGI (Clinical Global Impression) Scale. Psychopharmacol Bull 21:839-843
22. National Institute of Mental Health (1985b), AIMS (Abnormal Involuntary Movement Scale). Pychopharmacol Bull 21:1077-1080
23. National Institute of Mental Health (1985c), DOTES (Dosage Record and Treatment Emergent Symptom Scale). Psychopharmacol Bull 21:1067-1068
24. National Institute of Mental Health (1985d), TESS (Treatment Emergent Symptom Scale-Write-in). Pychopharmacol Bull 21:1069-1072
25. RifkinA, Karajgi B, Dicker R et al. (1997), Lithium treatment of conduct disorders in adolescents. Am J Psychiatry 154:554-555
26. Schreier HA (1998), Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 8:49-59
27. Simpson GM, Angus JWS (1970), A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19
28. Srigethy E, Wiznitzer M, Branicky LA, Maxwell K, Findling RL (1999), Risperidone-induced hepatotoxiciry in children and adolescents? A chart review study. J Child Adolesc Psychopharmacol 9:93-98